Current Medicinal Chemistry

Round and Round we Go: Cyclic Peptides in Disease
pp. 2221-2232(12)
Authors: Katsara, Maria; Tselios, Theodore; Deraos, Spyros; Deraos, George; Matsoukas, Minos-Timotheos; Lazoura, Eliada; Matsoukas, John; Apostolopoulos, Vasso

Gangliosides Potentially Inhibit Extracellular Nucleotide Metabolism
pp. 2233-2239(7)
Author: Hara-Yokoyama, Miki

Regulation of Inflammatory Responses by Sensory Neurons: Molecular Mechanism(s) and Possible Therapeutic Applications
pp. 2241-2251(11)
Authors: Okajima, Kenji; Harada, Naoaki

Quantitative Structure Activity Relationships as Useful Tools for the Design of New Adenosine Receptor Ligands. 1. Agonist
pp. 2253-2266(14)
Authors: Perez Gonzalez, Maykel; Teran, Carmen; Teijeira, Marta; Morales Helguera, Aliuska

Molecular Mechanisms of Respiratory Virus-Induced Asthma and COPD Exacerbations and Pneumonia
pp. 2267-2290(24)
Authors: Caramori, Gaetano; Ito, Kazuhiro; Contoli, Marco; Di Stefano, Antonino; L. Johnston, Sebastian; M. Adcock, Ian; Papi, Alberto

IL-13: A Promising Therapeutic Target for Bronchial Asthma
pp. 2291-2298(8)
Authors: Izuhara, K.; Arima, K.; Kanaji, S.; Ohta, S.; Kanaji, T.

Can siRNA Technology Provide the Tools for Gene Therapy of the Future?
pp. 2299-2307(9)
Authors: Racz, Zs; Hamar, P.

Inhibitors of Cathepsin B
pp. 2309-2327(19)
Authors: Frlan, R.; Gobec, S.

Current Status and Future Prospective of Immunointervention in Multiple Sclerosis
pp. 2329-2343(15)
Author: Cavaletti, Guido